NASDAQ : MGX
Metagenomi Therapeutics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 0.7803 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 29.48M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Metagenomi Therapeutics, Inc. (MGX) reported revenue of 13.56M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 13.56M | 25.21M | 52.30M | 44.76M | 17.20M | 243.00K |
| Cost of Revenue | 88.60M | 94.43M | 109.18M | 94.40M | 43.14M | 14.48M |
| Gross Profit | -75.03M | -69.22M | -56.88M | -49.65M | -25.94M | -14.23M |
| Selling, General & Admin | 25.53M | 26.79M | 32.02M | 28.84M | 18.70M | 9.71M |
| Operating Expenses | 25.53M | 26.79M | 32.02M | 28.84M | 18.70M | 9.71M |
| Operating Income | -100.57M | -96.01M | -88.90M | -78.49M | -44.64M | -23.95M |
| Interest Expense | -98.00K | -302.00K | ||||
| Interest & Investment Income | 6.89M | 9.47M | 14.72M | 15.47M | 3.42M | 43.00K |
| Other Non Operating Income (Expenses) | 21.00K | -91.00K | -207.00K | -74.00K | 201.00K | 4.00K |
| EBT Excluding Unusual Items | -93.65M | -86.63M | -74.39M | -63.10M | -41.12M | -24.20M |
| Gain (Loss) on Sale of Investments | -1.29M | -9.19M | 2.87M | 94.00K | 2.76M | |
| Pretax Income | -93.65M | -87.93M | -83.57M | -60.23M | -41.02M | -21.44M |
| Income Tax Expense | -190.00K | -58.00K | -5.51M | 8.03M | 2.57M | |
| Net Income | -93.46M | -87.87M | -78.06M | -68.25M | -43.59M | -21.44M |
| Net Income to Common | -93.46M | -87.87M | -78.06M | -68.25M | -43.59M | -21.44M |
| Shares Outstanding (Basic) | 37.52M | 37.25M | 33.03M | 3.40M | 3.40M | 5.69M |
| Shares Outstanding (Diluted) | 37.52M | 37.25M | 33.03M | 3.40M | 3.40M | 5.69M |
| EPS (Basic) | -2.49 | -2.36 | -2.36 | -20.05 | -12.82 | -3.77 |
| EPS (Diluted) | -2.49 | -2.36 | -2.36 | -20.05 | -12.82 | -3.77 |
| Free Cash Flow | -85.80M | -89.47M | -112.19M | -101.22M | 15.75M | 21.35M |
| Free Cash Flow Per Share | -2.29 | -2.40 | -3.40 | -29.73 | 4.63 | 3.75 |
| Gross Margin | -274.58% | -108.78% | -110.93% | -150.81% | ||
| Operating Margin | -741.58% | -380.85% | -170.00% | -175.38% | -259.53% | -9,854.73% |
| Profit Margin | -689.20% | -348.54% | -149.27% | -152.50% | -253.45% | -8,823.87% |
| Free Cash Flow Margin | -632.67% | -354.88% | -214.53% | -226.17% | 91.55% | 8,787.65% |
| EBITDA | -95.40M | -90.70M | -83.49M | -74.28M | -42.91M | -23.56M |
| EBITDA Margin | -159.66% | -165.98% | -249.46% | |||
| D&A For EBITDA | 5.16M | 5.32M | 5.41M | 4.21M | 1.73M | 387.00K |
| EBIT | -100.57M | -96.01M | -88.90M | -78.49M | -44.64M | -23.95M |
| EBIT Margin | -170.00% | -175.38% | -259.53% |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 39.03M | 41.72M | 27.39M | 140.60M | 184.44M | 39.30M |
| Short-Term Investments | 81.64M | 119.08M | 220.92M | 130.58M | 177.69M | 68.86M |
| Cash & Short-Term Investments | 120.66M | 160.80M | 248.31M | 271.18M | 362.13M | 108.15M |
| Accounts Receivable | 305.00K | 1.26M | 2.45M | 1.27M | ||
| Other Receivables | 900.00K | 1.20M | 1.60M | 1.00M | 300.00K | 490.00K |
| Receivables | 900.00K | 1.50M | 2.86M | 3.45M | 1.57M | 490.00K |
| Prepaid Expenses | 2.90M | 3.23M | 6.80M | 3.64M | 3.19M | 272.00K |
| Total Current Assets | 124.47M | 165.54M | 257.96M | 278.27M | 366.90M | 108.92M |
| Property, Plant & Equipment | 41.67M | 47.38M | 57.66M | 65.15M | 33.26M | 21.89M |
| Long-Term Investments | 2.15M | 2.15M | 3.45M | 10.68M | 7.81M | 6.42M |
| Long-Term Deferred Charges | 600.00K | 5.10M | 143.00K | |||
| Other Long-Term Assets | 5.41M | 5.43M | 5.54M | 5.64M | 6.52M | 4.63M |
| Total Assets | 173.70M | 221.10M | 324.60M | 364.84M | 414.49M | 141.99M |
| Accounts Payable | 2.60M | 1.49M | 533.00K | 1.79M | 2.01M | 1.35M |
| Accrued Expenses | 7.60M | 6.72M | 8.35M | 11.03M | 7.89M | 3.15M |
| Current Portion of Leases | 6.24M | 6.03M | 5.59M | 3.43M | 1.51M | 687.00K |
| Current Income Taxes Payable | 3.27M | 1.54M | ||||
| Current Unearned Revenue | 11.20M | 8.70M | 22.76M | 48.91M | 34.69M | 19.60M |
| Other Current Liabilities | 1.00K | 74.00K | 445.00K | 896.00K | 382.00K | |
| Total Current Liabilities | 27.63M | 22.93M | 37.31M | 68.86M | 48.54M | 25.17M |
| Long-Term Debt | 30.28M | |||||
| Long-Term Leases | 31.48M | 34.63M | 40.19M | 44.80M | 17.06M | 17.96M |
| Long-Term Unearned Revenue | 2.99M | 10.24M | 30.93M | 76.19M | 24.63M | |
| Other Long-Term Liabilities | 2.02M | 1.95M | 2.01M | 5.08M | 1.03M | |
| Total Liabilities | 61.13M | 62.51M | 89.74M | 149.67M | 142.81M | 98.04M |
| Common Stock | 4.00K | 4.00K | 4.00K | 26.00K | 26.00K | |
| Additional Paid-In Capital | 474.10M | 469.20M | 457.15M | 9.46M | ||
| Retained Earnings | -361.41M | -310.87M | -223.00M | -144.94M | -76.69M | -33.10M |
| Comprehensive Income & Other | -122.00K | 260.00K | 709.00K | -97.00K | 2.23M | 526.00K |
| Total Common Equity | 112.57M | 158.60M | 234.86M | -135.58M | -74.43M | -32.54M |
| Shareholders' Equity | 112.57M | 158.60M | 234.86M | 215.17M | 271.68M | 43.95M |
| Total Liabilities & Equity | 173.70M | 221.10M | 324.60M | 364.84M | 414.49M | 141.99M |
| Total Debt | 37.72M | 40.66M | 45.78M | 48.23M | 18.57M | 48.93M |
| Net Cash (Debt) | 82.94M | 120.14M | 202.53M | 222.95M | 343.56M | 59.23M |
| Net Cash Per Share | 2.21 | 3.23 | 6.13 | 65.49 | 101.06 | 10.41 |
| Filing Date Shares Outstanding | 37.78M | 37.62M | 37.38M | 37.47M | 5.95M | 5.69M |
| Total Common Shares Outstanding | 37.78M | 37.62M | 37.42M | 5.95M | 5.95M | 5.69M |
| Working Capital | 96.84M | 142.60M | 220.65M | 209.41M | 318.36M | 83.74M |
| Book Value Per Share | 2.98 | 4.22 | 6.28 | -22.80 | -12.51 | -5.72 |
| Tangible Book Value | 112.57M | 158.60M | 234.86M | -135.58M | -74.43M | -32.54M |
| Tangible Book Value Per Share | 2.98 | 4.22 | 6.28 | -22.80 | -12.51 | -5.72 |
| Machinery | 23.86M | 24.49M | 21.80M | 13.84M | 3.23M | |
| Construction In Progress | 143.00K | 2.35M | 1.40M | 887.00K | ||
| Leasehold Improvements | 4.39M | 4.38M | 3.83M | 3.53M | 293.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -93.46M | -87.87M | -78.06M | -68.25M | -43.59M | -21.44M |
| Depreciation & Amortization | 5.16M | 5.32M | 5.41M | 4.21M | 1.73M | 387.00K |
| Asset Writedown & Restructuring Costs | 955.00K | 502.00K | 1.04M | 23.00K | 282.00K | |
| Loss (Gain) From Sale of Investments | -1.73M | -1.71M | 3.02M | -11.34M | -1.22M | -2.56M |
| Stock-Based Compensation | 10.52M | 11.85M | 16.20M | 6.92M | 1.96M | 375.00K |
| Other Operating Activities | 5.22M | 5.11M | 2.98M | 3.46M | 1.08M | 1.24M |
| Change in Accounts Receivable | 873.00K | 952.00K | 1.19M | -1.18M | -1.27M | |
| Change in Accounts Payable | -116.00K | 1.05M | -1.11M | -84.00K | 721.00K | 695.00K |
| Change in Unearned Revenue | -11.17M | -21.10M | -46.80M | -30.30M | 65.66M | 44.23M |
| Change in Income Taxes | -3.27M | 1.73M | 1.54M | |||
| Change in Other Net Operating Assets | -1.74M | -3.00M | -9.69M | 3.40M | 2.84M | 1.33M |
| Operating Cash Flow | -85.49M | -88.89M | -109.07M | -91.41M | 29.72M | 24.26M |
| Capital Expenditures | -309.00K | -574.00K | -3.11M | -9.81M | -13.98M | -2.90M |
| Sale of Property, Plant & Equipment | 37.00K | |||||
| Investment in Securities | 97.19M | 104.07M | -85.04M | 55.55M | -108.22M | -71.41M |
| Investing Cash Flow | 96.88M | 103.53M | -88.16M | 45.73M | -122.20M | -74.32M |
| Long-Term Debt Issued | 29.97M | |||||
| Net Debt Issued (Repaid) | 29.97M | |||||
| Issuance of Common Stock | 167.00K | 202.00K | 84.01M | |||
| Other Financing Activities | -240.00K | -558.00K | -3.28M | |||
| Financing Cash Flow | -73.00K | -356.00K | 84.01M | 1.01M | 239.59M | 39.92M |
| Net Cash Flow | 11.32M | 14.28M | -113.22M | -44.66M | 147.12M | -10.14M |
| Free Cash Flow | -85.80M | -89.47M | -112.19M | -101.22M | 15.75M | 21.35M |
| Free Cash Flow Margin | -632.67% | -354.88% | -214.53% | -226.17% | 91.55% | 8,787.65% |
| Free Cash Flow Per Share | -2.29 | -2.40 | -3.40 | -29.73 | 4.63 | 3.75 |
| Levered Free Cash Flow | -50.95M | -53.31M | -73.35M | -31.65M | -19.71M | |
| Unlevered Free Cash Flow | -50.95M | -53.31M | -73.35M | -31.65M | -19.65M | |
| Cash Interest Paid | 2.16M | 1.45M | ||||
| Cash Income Tax Paid | -2.24M | 3.50M | 2.25M | |||
| Change in Working Capital | -12.16M | -22.09M | -59.67M | -26.43M | 69.49M | 46.26M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 29.48M | 60.83M | 135.10M | |||
| Enterprise Value | -53.47M | -81.63M | -93.41M | |||
| Last Close Price | 0.78 | 1.62 | 3.61 | |||
| PS Ratio | 2.17 | 2.41 | 2.58 | |||
| PB Ratio | 0.26 | 0.38 | 0.57 | |||
| P/TBV Ratio | 0.26 | 0.38 | 0.57 | |||
| Debt / Equity Ratio | 0.34 | 0.26 | 0.20 | 0.22 | 0.07 | 1.11 |
| Debt / FCF Ratio | 1.18 | 2.29 | ||||
| Net Debt / Equity Ratio | -0.74 | -0.76 | -0.86 | -1.04 | -1.26 | -1.35 |
| Net Debt / EBITDA Ratio | 0.87 | 1.32 | 2.43 | 3.00 | 8.01 | 2.51 |
| Net Debt / FCF Ratio | 0.97 | 1.34 | 1.80 | 2.20 | -21.82 | -2.77 |
| Asset Turnover | 0.06 | 0.09 | 0.15 | 0.12 | 0.06 | |
| Quick Ratio | 4.40 | 7.08 | 6.73 | 3.99 | 7.49 | 4.32 |
| Current Ratio | 4.50 | 7.22 | 6.91 | 4.04 | 7.56 | 4.33 |
| Return on Equity (ROE) | -60.61% | -44.66% | -34.69% | -28.04% | -27.62% | |
| Return on Assets (ROA) | -28.19% | -21.99% | -16.12% | -12.59% | -10.03% | |
| Return on Capital Employed (ROCE) | -68.80% | -48.40% | -30.90% | -26.50% | -12.20% | -20.50% |
| Earnings Yield | -319.26% | -144.46% | -57.78% | |||
| FCF Yield | -291.06% | -147.09% | -83.04% | |||
| Buyback Yield / Dilution | -1.06% | -12.79% | -870.10% | -0.15% | 40.27% |